Nuno Verdasca
Overview
Explore the profile of Nuno Verdasca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antunes L, Rojas-Castro M, Lozano M, Martinez-Baz I, Leroux-Roels I, Borg M, et al.
Influenza Other Respir Viruses
. 2025 Mar;
19(3):e70081.
PMID: 40059069
We estimated the effectiveness of the adapted monovalent XBB.1.5 COVID-19 vaccines against PCR-confirmed SARS-CoV-2 hospitalisation during the BA.2.86/JN.1 lineage-predominant period using a multicentre test-negative case-control study in Europe. We included...
2.
Cordeiro R, Pelerito A, de Carvalho I, Lopo S, Neves R, Rocha R, et al.
J Med Virol
. 2024 Dec;
96(12):e70104.
PMID: 39654358
Mpox is a zoonotic disease caused by the Monkeypox virus (MPXV), and since May 2022, tens of thousands of cases have been reported in non-endemic countries. We aimed to evaluate...
3.
Merdrignac L, Laniece Delaunay C, Verdasca N, Vega-Piris L, ODonnell J, Seve N, et al.
Influenza Other Respir Viruses
. 2024 Nov;
18(11):e70009.
PMID: 39523781
We estimated XBB.1.5 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection among adults aged ≥ 65 years during the 2023/2024 JN.1 lineage-predominant period in a European multi-country test-negative case-control study at...
4.
Kislaya I, Torres A, Gomes L, Melo A, Machado A, Henriques C, et al.
Hum Vaccin Immunother
. 2023 Nov;
19(3):2263219.
PMID: 37964588
Using a test-negative case-control design, we aim to estimate influenza vaccine effectiveness (VE) against medically attended laboratory-confirmed influenza in Portugal in 2022/2023 season. Between week 41/2022 and week 14/2023, data...
5.
Torres A, Gomez V, Kislaya I, Rodrigues A, Fernandes Tavares M, Pereira A, et al.
Can J Infect Dis Med Microbiol
. 2023 Feb;
2023:6590011.
PMID: 36846348
Background: Severe acute respiratory infections (SARI) surveillance is recommended to assess the severity of respiratory infections disease. In 2021, the National Institute of Health Doutor Ricardo Jorge, in collaboration with...
6.
Torres A, Guiomar R, Verdasca N, Melo A, Rodrigues A
Acta Med Port
. 2023 Jan;
36(5):343-352.
PMID: 36705636
Introduction: An out-of-season increase in respiratory syncytial virus (RSV) incidence was observed in Portugal from June 2021 onwards, revealing a continuing surge in cases throughout 2021/2022 autumn/winter. We aimed to...
7.
Kislaya I, Goncalves P, Gomez V, Gaio V, Roquette R, Barreto M, et al.
Infect Dis (Lond)
. 2022 Jan;
54(6):418-424.
PMID: 35023439
Background: Integrated approaches to surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection are important for public health actions. The 2nd National Serological Survey (ISN2COVID-19) aimed to characterize the...
8.
Oliveira A, Verdasca N, Pista A
J Med Virol
. 2013 Aug;
85(7):1235-41.
PMID: 23918542
Persistent infection by high-risk human papillomavirus is a necessary cause for cervical cancer. DNA-based human papillomavirus (HPV) assays show high sensitivity but poor specificity in detecting high-grade cervical lesions. Assays...
9.
Oliveira A, Delgado C, Verdasca N, Pista A
Acta Med Port
. 2013 Jul;
26(2):139-44.
PMID: 23809746
Introduction/objective: Persistent infection with high-risk human papillomavirus (HPV) types is a necessary cause for cervical cancer development. The aim of this study was to evaluate the significance of different molecular...
10.
Pista A, Verdasca N, Oliveira A
J Med Virol
. 2010 Dec;
83(2):272-6.
PMID: 21181922
Persistent infection by high-risk human papillomavirus (HR-HPV) is a cause of cervical cancer. The use of HPV detection in cervical screening programs may improve the ability to identify women at...